Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 15/20 | 0.50 |
| ▸ | CTSK | P43235 | 14/20 | 0.50 |
| ▸ | CTSL | P07711 | 2/20 | 0.46 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3238402 | 0.92 | CTSS (0.50) | CTSSCTSKCTSLCTSBCA1 | |
| SCHEMBL3238391 | 0.92 | CTSS (0.50) | CTSSCTSKCTSLCTSBCA1 | |
| SCHEMBL8185522 | 0.88 | CTSK (0.60) | CTSSCTSK | |
| SCHEMBL8089326 | 0.86 | CTSK (0.56) | CTSSCTSKCTSLCTSB | |
| SCHEMBL8089323 | 0.86 | CTSK (0.56) | CTSSCTSKCTSLCTSB | |
| SCHEMBL8183200 | 0.85 | CTSK (0.45) | CTSSCTSKCTSLCTSBCA1 | |
| SCHEMBL6654092 | 0.84 | CTSK (0.58) | CTSSCTSKCTSLCTSBCA1 | |
| SCHEMBL16119979 | 0.83 | CTSK (0.45) | CTSSCTSKCTSLCTSBCA1 | |
| SCHEMBL3263928 | 0.82 | CTSS (0.51) | CTSSCTSKCTSLCTSBCA1 | |
| SCHEMBL5958657 | 0.80 | CTSK (0.56) | CTSSCTSKCTSLCTSBCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376477-A2 | STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES | Taigen Biotechnology Co., Ltd. (TW) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010077798-A2 | STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-07-08 | — | — | WO | disclosed |
| US-20100152452-A1 | STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152452-A1 | STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES | DHPS, AZI2, DPYD | CTSS 3427/4885CTSK 4224/4885CTSL 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.